Lantheus Holdings (LNTH) Interest Expenses (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Interest Expenses of $49.0 million for Q1 2026, up 107.0% year-over-year from $23.7 million in Q1 2025, and up 334.22% quarter-over-quarter from $11.3 million in Q4 2025.
Lantheus Holdings (LNTH) Interest Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Interest Expenses for 13 consecutive years, with $49.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 107.0% year-over-year to $49.0 million; the TTM figure through Mar 2026 stood at $49.0 million (up 107.0% YoY), while the FY2025 annual figure was $180.5 million, down 99.49% from the prior year.
- Interest Expenses advanced to $49.0 million in Q1 2026 per LNTH's latest filing, from $11.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $57.9 million in Q3 2025 and bottomed at -$504000.0 in Q4 2022.
- Historically, Interest Expenses has averaged $22.5 million across 5 years, with a median of $23.6 million in 2025.
- Annual changes were most pronounced in 2024 — Interest Expenses plunged 91.98% — and 2025, when it jumped 3568.78%.
- Lantheus Holdings' Interest Expenses stood at -$504000.0 in 2022, then soared by 181.15% to $409000.0 in 2023, then surged by 1946.21% to $8.4 million in 2024, then jumped by 34.95% to $11.3 million in 2025, then jumped by 334.22% to $49.0 million in 2026.
- Business Quant data shows LNTH's Interest Expenses at $49.0 million in Q1 2026, $11.3 million in Q4 2025, and $57.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 4.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 49.04 Mn |
| Jun 30, 2026 | 49.04 Mn |
| Mar 31, 2026 | 49.04 Mn |
| Mar 31, 2026 | 49.04 Mn |
| Dec 31, 2025 | 11.29 Mn |
| Dec 31, 2025 | 11.29 Mn |
| Sep 30, 2025 | 57.93 Mn |
| Sep 30, 2025 | 57.93 Mn |
| Jun 30, 2025 | 23.65 Mn |
| Jun 30, 2025 | 23.65 Mn |
| Mar 31, 2025 | 23.69 Mn |
| Mar 31, 2025 | 23.69 Mn |
| Dec 31, 2024 | 8.37 Mn |
| Dec 31, 2024 | 8.37 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 21.95 Mn |
| Jun 30, 2024 | 21.95 Mn |
| Mar 31, 2024 | 16.20 Mn |
| Mar 31, 2024 | 16.20 Mn |